［1］Roman E, Smith AG. Epidemiology of lymphomas[J].Histopathology, 2011, 58(1): 4-14.
［2］Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(1): 9-29.
［3］Tsimberidou AM. OB’rien S,khouri I,et al.clinical outcomes and prognostic factors in patients with richter[J]. s syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.J Clin Oncol, 2006, 24(15): 2343-2351.
［4］Tsimberidou AM, Keating MJ. Richter syndrome: biology, incidence, and therapeutic strategies[J]. Cancer, 2005, 103(2): 216-228.
［5］Tsimberidou AM, O’brien S, Kantarjian HM, et al. Hodgkin transformation of chronic lymphocytic leukemia:the M[J]. Cancer, 2006, 107(6): 1294 1302.
［6］王建祥, 邱录贵, 沈志祥, 等 . 中国慢性淋巴细胞白血病的诊断 与治疗指南 [J]. 中华血液学杂志 , 2011, 32(7): 498-501.
［7］ 陈冰, 张帆, 卢林明, 等. 中国皖南地区 728 例恶性淋巴瘤的构成分析[J]. 中国临床药理学与治疗学, 2013, 18(4): 388-393.
［8］ ZHANG Siwei, LEI Zhenglong, LI Guanglin, et al. A Report of Cancer Incidence and Mortality from 34 Cancer Registries in China, 2006[J]. China Cancer, 2010, 19(6): 356-365.
［9］Maddocks-Christianson K, Slager SL, Zent CS, et al. Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia[J]. Br J Haematol, 2007, 139(3): 398-404.
［10］ Tsimberidou AM, Keating MJ. Richter’s transformation in chronic lymphocytic leukemia[J]. Semin Oncol, 2006, 33(2): 250-256.
［11］ Smit LA, Van MF, Langerak AW, et al. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter’s transformation[J]. Hematologica, 2006, 91(7): 903-911.
［12］Kim JM, Ko YH, Lee S S. WHO classification of malignant lymphomas in Korea: report of the third nationwide study[J]. Korean J Pathol, 2011, 45(3): 254-260.
